• четверть стакана измельченного лука – шалота;
• четверть стакана грубо нарезанной свежей петрушки;
• одна чайная ложка сушеного орегано;
• пол чайной ложки чесночного порошка;
• одна чайная ложка морской соли;
• пол чайной ложки цедры лимона;
• одна столовая ложка масла авокадо.
1. Натрите цукини и поместите в марлю, чтобы избавиться от излишков влаги.
2. В миске среднего размера смешайте фарш, лук, петрушку, орегано, чесночный порошок, соль и лимонную цедру.
3. Сожмите марлю с цукини, чтобы избавиться от излишков влаги. Добавьте цукини в фарш и перемешайте.
4. Слепите небольшие котлеты.
5. Разогрейте сковороду на умеренно сильном огне, добавьте масло авокадо. Жарьте котлеты по три минуты с каждой стороны до легкой золотистой корочки и полной готовности.
Приложения
Ответы на тест «Разрушение мифов о менструальном цикле»
1. Ложь
2. Ложь
3. Ложь
4. Правда
5. Ложь
6. Ложь
7. Ложь
8. Ложь
9. Правда
10. Ложь
Ваш пятый основной физиологический показатель
Список литературы
1. О противозачаточных начистоту
Akinloye, O., et al. “Effects of Contraceptives on Serum Trace Elements, Calcium, and Phosphorus Levels”. West Indian Medical Journal 60, no. 3 (2011): 308–15.
Aminzadeh, A., et al. “Frequency of Candidiasis and Colonization of Candida Albicans in Relation to Oral Contraceptive Pills”. Iran Red Crescent Medical Journal 18, no. 10 (2016): e38909.
Anderson, K. E., et al. “Effects of Oral Contraceptives on Vitamin Metabolism”. Advances in Clinical Chemistry 18 (1976): 247–87.
Bird, S. T., et al. “Irritable Bowel Syndrome and Drospirenone-Containing Oral Contraceptives; A Comparative-Safety Study”. Current Drug Safety 7, no. 1 (2012): 8–15.
Centers for Disease Control, Cancer and Steroid Hormone Study. “Long-Term Oral Contraceptive Use and the Risk of Breast Cancer”. JAMA 249, no. 12 (1983): 1591–95.
Chasan-Taber, L., et al. “Epidemiology of Oral-Contraceptives and Cardiovascular Disease”. Annals of Internal Medicine 128, no. 6 (1998): 467–77.
Davidson, N. E., et al. “Good News About Oral Contraceptives”. New England Journal of Medicine 346 (2002): 2078–79.
Davis, A. R., et al. “Occurrence of Menses or Pregnancy After Cessation of a Continuous Oral Contraceptive”. Fertility and Sterility 89, no. 5 (2008): 1059–63.
Dreon, D. M., et al. “Oral Contraceptive Use and Increased Plasma Concentration of C-Reactive Protein”. Life Sciences 73, no. 10 (2003): 1245–52.
Dunn, N., et al. “Oral Contraceptives and Myocardial Infarction: Results of the MICA Case Control Study”. British Medical Journal 318, no. 7198 (1999): 1579–84.
Fröhlich, M., et al. “Oral Contraceptive Use Is Associated with a Systemic Acute Phase Response”. Fibrinolysis and Proteolysis 13, no. 6 (1999): 239–44.
Gingnell, M., et al. “Oral Contraceptive Use Changes Brain Activity and Mood in Women with Previous Negative Affect on the Pill – A Double-Blinded, Placebo-Controlled Randomized Trial of a Levonorgestrel-Containing Combined Oral Contraceptive”. Psychoneuroendocrinology 38, no. 7 (2013): 1133–44.
Hankinson, S. E., et al. “A Prospective Study of Oral Contraceptive Use and Risk of Breast Cancer (Nurses’ Health Study, United States)”. Cancer Causes and Control 8, no. 1 (1997): 65–72.
Hertel, J., et al. “Evidence for Stress-Like Alterations in the HPA-Axis in Women Taking Oral Contraceptives”. Scientific Reports 7, no. 1 (2017): 14111.
Hickman, R. J., et al. “C-Reactive Protein Is Elevated in Atypical but Not Nonatypical Depression: Data from the National Health and Nutrition Examination Survey (NHANES) 1999–2004”. Journal of Behavioral Medicine 37, no. 4 (2014): 621–29.
Hock, H. “The Pill and the College Attainment of American Women and Men”. Florida State University, September 15, 2005. http://paa2006.princeton.edu/papers/61745.
Jenkins, T. A., et al. “Influence of Tryptophan and Serotonin on Mood and Cognition with a Possible Role of the Gut-Brain Axis”. Nutrients 8, no. 1 (2016): 56.
Khalili, H., et al. “Oral Contraceptives, Reproductive Factors, and Risk of Inflammatory Bowel Disease”. Gut 62, no. 8 (2013): 1153–59.
Khier, L. A. M. “Effects of Oral Contraceptives on the Thyroid Function in Sudanese Females”. BS thesis, University of Khartoum, 2000. https://core.ac.uk/download /pdf/71669046.pdf.
Kluf, C., et al. “Pro-Inflammatory Effects of Oestrogens During Use of Oral Contraceptives and Hormone Replacement Treatment”. Vascular Pharmacology 39, no. 3 (2002): 149–54.
Kulkami, J. “Depression as a Side Effect of the Contraceptive Pill”. Expert Opinion on Drug Safety 6, no. 4 (2007): 371–74.
Lewis, M. A., et al. “Third Generation Oral Contraceptives and Risk of Myocardial Infarction: An International Case-Control Study. Transnational Research Group on Oral Contraceptives and the Health of Young Women”. British Medical Journal 312, no. 7023 (1996): 88–90.
Maes, M., et al. “The Effects of Glucocorticoids on the Availability of L-Tryptophan and Tyrosine in the Plasma of Depressed Patients”. Journal of Affective Disorders 18, no. 2 (1990): 121–27. Marchbanks, P. A., et al. “Oral Contraceptives and the Risk of Breast Cancer”. New England Journal of Medicine 346 (2002): 2025–32.
Montoya, E. R., et al. “How Oral Contraceptives Impact Social-Emotional Behavior and Brain Function”. Trends in Cognitive Sciences 21, no. 2 (2017): 125–36.
Myint, A. M., et al. “The Role of the Kynurenine Metabolism in Major Depression”. Journal of Neural Transmission 119, no. 2 (2012): 245–51.
Nassaralla, C. L., et al. “Characteristics of the Menstrual Cycle after Discontinuation of Oral Contraceptives”. Journal of Women’s Health 20, no. 2 (2011): 169–77.
Oinonen, K. A., et al. “To What Extent Do Oral Contraceptives Influence Mood and Affect?” Journal of Affective Disorders 70, no. 3 (2002): 229–40.
